Danaher Total Equity increased by 0.8% to $52.95B in Q1 2026 compared to the prior quarter. Year-over-year, this metric grew by 4.1%, from $50.85B to $52.95B. Over 5 years (FY 2020 to FY 2025), Total Equity shows an upward trend with a 5.7% CAGR. This is a positive signal — higher values indicate stronger performance for this metric.
An increasing trend generally indicates profitable operations and reinvestment, whereas a declining trend may signal share buybacks, dividend payouts exceeding earnings, or net losses.
Total stockholders' equity represents the residual interest in the assets of the company after deducting all liabilities...
Standardized across all public companies; peers in the life sciences sector typically maintain strong equity bases to support R&D and M&A.
total_stockholders_equity| Q2 '21 | Q3 '21 | Q4 '21 | Q1 '22 | Q2 '22 | Q3 '22 | Q4 '22 | Q1 '23 | Q2 '23 | Q3 '23 | Q4 '23 | Q1 '24 | Q2 '24 | Q3 '24 | Q4 '24 | Q1 '25 | Q2 '25 | Q3 '25 | Q4 '25 | Q1 '26 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Value | $42.76B | $43.45B | $45.17B | $46.36B | $46.59B | $46.99B | $50.08B | $51.48B | $51.72B | $52.41B | $53.49B | $53.44B | $49.90B | $51.30B | $49.54B | $50.85B | $52.33B | $51.07B | $52.53B | $52.95B |
| QoQ Change | — | +1.6% | +3.9% | +2.6% | +0.5% | +0.8% | +6.6% | +2.8% | +0.5% | +1.3% | +2.1% | -0.1% | -6.6% | +2.8% | -3.4% | +2.6% | +2.9% | -2.4% | +2.9% | +0.8% |
| YoY Change | — | — | — | — | +9.0% | +8.1% | +10.9% | +11.0% | +11.0% | +11.5% | +6.8% | +3.8% | -3.5% | -2.1% | -7.4% | -4.9% | +4.9% | -0.4% | +6.0% | +4.1% |